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Open Surgical Techniques for Repair of Type 3 and 4
Thoracoabdominal Aortic Aneurysms: Is One Better
Than the Others?
Muhammad Ali A. Rana, Peter Gloviczki, Harbuzariu
Catalin, Audra Duncan, Manju Kalra, Gustavo S.
Oderich, Mark D. Fleming, Thomas C. Bower. Vascular
and Endovascular Surgery, Mayo Clinic, Rochester, Minn
Objectives: Various techniques are used for repair of
thoracoabdominal aortic aneurysms (TAAAs). This study
compares outcomes following repair of type 3 and 4
TAAAs using 3 different techniques at a tertiary care insti-
tution over the same time period.
Methods: 121 consecutive patients (83 male, 38
female) with 52 type 3 and 69 type 4 TAAAs underwent
elective repair between 1999 and 2011. Group 1 (65 pa-
tients) - clamp and sew technique; Group 2 (31 patients) -
left atrio-femoral bypass; Group 3 (25 patients) - visceral
branching technique of Ballard. There was no difference
in cardiac and pulmonary risk factors, aneurysm size, or
presence of dissection; 12% of group 3 was on dialysis
preoperatively (vs 2% and 0% in groups 1 & 2). 84% of
the patients had peri-operative spinal ﬂuid drainage.
Results: Procedure duration was longest in Group 3
(9.1 vs 7.7 & 5.7 hours, for 1&2; P < .001) but transfu-
sion requirement was largest in Group 2 (3.5 liters vs 1.7
& 2.1, for 1 and 3). Mean ICU and hospital stays were
the same (9, 10 and 8 days: P ¼ .82; 18, 20 & 18 days:
P ¼ .76). Cardiac (P ¼ .82), respiratory (P ¼ .43), and
renal (P ¼ .07) complications were not different between
groups. Spinal cord injury occurred in 6% and it was not
different among groups (3, 10 & 8%; P ¼ .21). Thirty-
day mortality was 6.6%, not different in groups 1-3 (6%,
10%, 4%; P ¼ .68). Median follow-up was 45(642)
months with median survival of 84, 73 and 40 months in
Groups 1-3, respectively (P ¼ .49). Estimated overall
survival at 5 and 10 years was 65 and 23%.
Conclusions: For repair of types 3 and 4 TAAAs the
Ballard aortic branching technique had the longest duration
but the clamp and sew technique had the lowest transfusion
requirements. Complications, early and late mortality, and
spinal cord injury were the same using the clamp and sew
technique, atrio-femoral bypass or the Ballard techniques.
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Endovascular Therapy Is Increasingly Utilized in the
Modern Management of Acute Aortic Occlusion but
Has Not Improved Outcomes
William P. Robinson, Rupal Patel, Jesse Columbo,
Francesco A. Aiello, Andres Schanzer, Donald T. Baril,
Elias J. Arous, Louis M. Messina. Division of Vascular
and Endovascular Surgery, University of Massachusetts
Medical School, Worcester, Mass
Objectives: Published series of acute infrarenal aortic
occlusion (AAO) predate the widespread application of
endovascular therapy in the last decade. We aimed to
examine the modern management and outcomes of
AAO, including the impact of endovascular therapy.
Methods: We reviewed consecutive patients with AAO
at a tertiary referral center from 2004-2012. Outcomes were
stratiﬁed according to etiology and procedure performed.
Results: AAO in 30 patients was due to in situ throm-
bosis (IST) in 21(70%) and embolism in 9(30%) patients.
Neurologic deﬁcit was present in 15(50%) patients,
including 6 with paresis secondary to spinal ischemia.
Patients with embolism were older (78 6 7 vs 66 6 12
years; P ¼ .01) and had higher rates of atrial ﬁbrillation
(89% vs 25%; P ¼ .001) and CHF (67% vs 5%; P ¼
.0003) in comparison to those with IST. 29 patients
underwent procedures: transfemoral embolectomy (n ¼
6), aortoiliac thrombectomy (n ¼ 2), axillobifemoral
bypass (n ¼ 10), aortobifemoral bypass (n ¼ 6) and endo-
vascular therapy including thrombolysis, angioplasty 6
stenting (n ¼ 5). Endovascular therapy was used for both
embolism and IST. Mortality did not vary signiﬁcantly
according to etiology (embolism: 44% vs IST: 24%) but
varied widely according to procedure (transfemoral embo-
lectomy: 50%, aortoiliac thrombectomy: 100%, axillobife-
moral bypass: 30%, aortobifemoral bypass: 0%, and
endovascular therapy: 20%; P ¼ .05). Major morbidity
(57%), length of stay (7 6 7days), and discharge to a
rehabilitation facility (52%) did not vary by etiology or
procedure. Among in-hospital survivors, long-term ampu-
tation-free survival was 90% at a mean follow-up of 455 6
488 days.
Conclusions: Endovascular therapy is increasingly
utilized in the modern management of AAO in comparison
to historical controls but has not improved outcomes. AAO
remains a heterogeneous condition managed via a variety
of endovascular and surgical procedures. The modern
management of AAO is associated with signiﬁcant
morbidity and mortality, but reasonable prognosis can be
expected for survivors.
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Schanzer: Nothing to disclose.Table. Odds ratios for bivariate comparisons of 30-day
outcomes, stratiﬁed by procedure
30-day death,
stroke, MI
Preop ipsilateral
symptom type
Multivariate (adjusted)
logistic model
OR (95% CI) P value
CAS (n ¼ 3236) CVA (v TIA) 1.33 (0.88-2.02) .1812
CVA (v TMB) 2.86 (1.36, 6.01) .0056a
CVA (v ASX) 2.47 (1.70, 3.58) <.0001a
TIA (v TMB) 2.15 (1.04, 4.46) .0393
TIA (v ASX) 1.86 (1.32, 2.62) .0004a
TMB (v ASX) 0.86 (0.43, 1.75) .6857
CEA (n ¼ 5780) CVA (v TIA) 1.30 (0.83, 2.03) .2492
CVA (v TMB) 2.56 (1.18, 5.57) .0174
CVA (v ASX) 2.10 (1.45, 3.05) <.0001a
TIA (v TMB) 1.97 (0.91, 4.26) .0837
TIA (v ASX) 1.62 (1.13, 2.31) .0084
TMB (v ASX) 0.82 (0.40, 1.70) .5917
aDenotes signiﬁcant P-values of <.0083, accounting for multiple
comparisons.PVSS4.
Revascularization of Asymptomatic Carotid Stenosis Is
Not Appropriate in Patients on Dialysis
Joseph Sidaoui, Theodore H. Yuo, Luke K. Marone, Larry
Fish, Michel Makaroun, Rabih Chaer. Surgery, UPMC,
Pittsburgh, Pa
Objectives: Outcomes of carotid endarterectomy
(CEA) or angioplasty and stenting (CAS) for asymptomatic
disease in patients on dialysis are not well characterized,
with questionable stroke prevention and survival. This
study reports outcomes of carotid revascularization in
asymptomatic US dialysis patients.
Methods: Using US Renal Data System (USRDS)
databases, we identiﬁed all dialysis patients who underwent
CEA and CAS for asymptomatic disease from 2005-2008.
CEA and CAS were identiﬁed by CPT codes, and symptom
status and comorbidities by ICD9 codes. Primary
outcomes were stroke, cardiac complications and death at
30 days, and at 1 and 3 years. Predictors of mortality
were identiﬁed using regression models.
Results: Out of 738,561 dialysis patients, 2131
asymptomatic patients had carotid revascularization
(1805 CEA, 326 CAS). The mortality rate was 4.7% at
30 days (4.6% CEA, 4.9% CAS; P ¼ .81), and 24.6% at
1yr (23.8% CEA, 29.7% CAS; P ¼ .054). Kaplan Meier
estimates of survival were 75.1% at 1yr (75.9% CEA,
70.7% CAS; P ¼ .17), and 43.1% at 3 yrs (43.4% CEA,
41.7% CAS; P ¼ .58). Stroke rate was 6.5% at 30 days
(6.4% CEA, 6.8% CAS; P ¼ .81) and 13.6% at 1yr
(13.3% CEA, 15.3% CAS; P ¼ .43). Cardiac complications
occurred in 22.0% of patients (3.2% MI) at 30 days (22.2%
CEA, 20.7% CAS; P ¼ .69). The combined stroke or death
rate was 10.2% at 30 days (10.0% for CEA, and 11.1% for
CAS; P ¼ .56), and 33.5% at 1 year (32.2% CEA, 40.6%
CAS; P ¼ .013). Age > 70, time on dialysis, and history
of transplant were predictive of mortality. Compared to
the general population, patients who underwent CEA or
CAS had increased mortality (P < .001).
Conclusions: Patients on dialysis have high peri-oper-
ative and long term stroke or death rates following CEA or
CAS for asymptomatic stenosis. Carotid intervention in
these patients appears to be inappropriate.
Author Disclosures: R. Chaer: Nothing to disclose; L.
Fish: Nothing to disclose; M. Makaroun: Nothing to
disclose; L. K. Marone: Nothing to disclose; J. Sidaoui:
Nothing to disclose; T. H. Yuo: Nothing to disclose.Table. Comorbidities and risk factors by type of procedure
CEA, No. (%)
Age (in years, mean 6 SD) Sex
(Male) Diabetes History of
transplant Ischemic heart
disease PVD Hypertension
Smokers Presence of neoplasm
Time on dialysis (in years,
mean 6 SD) BMI (mean 6 SD)
69.1 (9.46) 1116 (60.3%) 997 (55.5%)
261 (14.1%) 399 (39.8%) 447 (24.9%)
1545 (85.9%) 149 (8.3%) 92 (5.1%)
3.5 (3.95) 27.8 (6.42)PVSS5.
Preoperative Symptom Type Inﬂuences the Early
Outcomes of Carotid Endarterectomy (CEA) and
Carotid Stenting (CAS) in the Society for Vascular
Surgery Vascular Registry (SVS-VR)
Patrick Geraghty1, Thomas E. Brothers2, David L. Gillespie3,
Gilbert R. Upchurch4, Michael C. Stoner5, Flora S. Siami6,
Christopher T. Kenwood6, Philip P. Goodney7.
1Washington University School of Medicine, St Louis, MO;
2Medical University of South Carolina, Charleston, SC;
3University of Rochester Medical Center, Rochester, NY;
4University of Virginia Medical School, Charlottesville, VA;
5East Carolina University, Greenville, NC; 6New England
Research Institutes, Inc, Watertown, MA; 7Dartmouth-
Hitchcock Medical Center, Lebanon, NH
Objectives: To determine the effect of speciﬁc
symptom types on outcomes of CEA and CAS in contem-
porary vascular surgical practice.
Methods: Retrospective review of all SVS-VR patients
treated with CEA or CAS. Patients were segregated by 12-
month preprocedural ipsilateral symptom status: stroke
(CVA), hemispheric transient ischemic attack (TIA), tran-
sient monocular blindness (TMB), or asymptomatic
(ASX). Simple and risk-adjusted odds ratios were used to
compare the likelihood of the 30-day outcomes of death,
CVA, myocardial infarction (MI), and the composite
outcomes of death/CVA, and death/CVA/MI.
Results: Symptom type signiﬁcantly inﬂuences risk-
adjusted 30-day outcomes for carotid intervention, more
markedly in patients undergoing CAS than CEA (Table).
Bivariate analyses conﬁrm a hierarchical relationship, withCAS, No. (%) P value
69.1 (8.98) 213 (64.0%) 189 (57.6%)
38 (11.4%) 61 (35.5%) 94 (28.7%)
276 (84.2%) 18 (5.5%) 22 (6.7%)
3.2 (3.60) 28.0 (6.64)
.99 .21 .47 .19 .28 .15 .40
.08 .24 .30 .71
